Clinical Trial Update: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Linaprazan Glurate to Lansoprazole in participants with erosive esophagitis due to gastroesophageal reflux disease; currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)
• Linaprazan Glurate (linaprazan)

Snippet

Sponsor: Cinclus Pharma Holding AB | Conditions: GERD (Gastroesophageal Reflux Disease) | Phase 3 | Status: NOT_YET_RECRUITING